Aflac Incorporated (AFL) Q3 2026 earnings review
Aflac U.S. profit jumps, but investment losses cut net earnings
Aflac's U.S. insurance business and share buybacks cushioned a smaller annual reserve release in Japan, while bond sales and loan write-downs cut net profit. Profit per share excluding one-offs dipped 2% to $2.43, as the annual review of insurance assumptions released $453 million of reserves against $580 million a year ago. Chief executive Daniel P. Amos highlighted that the insurer transferred ¥500 billion of Japanese cancer reserves to its Bermuda unit and returned $1.1 billion to shareholders.
| Profit per share, excluding one-offs | $2.43 -2.4% from a year ago (-1.2% before currency) |
|---|---|
| Net earnings (U.S. GAAP) | $303M -81.5% on $1.1B of investment and loan losses |
| Aflac U.S. pretax profit, excluding one-offs | $493M +31.5% from a year ago |
| Fourth-quarter dividend outlook | $0.61 Unchanged from Q3; +5.2% from a year ago |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because underlying profit before the annual reserve release held steady, while the balance sheet paid the price for higher yields. Aflac U.S. sales and policy retention improved, and moving Japanese reserves to Bermuda is freeing capital as planned. The bad news: selling older bonds triggered $842 million of realized losses and a $51 million tax write-off, while commercial loan credit losses reached $102 million.
The question now is whether Aflac's bond swaps and Bermuda reserve transfers can lift cash earnings without further eroding underlying book value and tax assets. Either higher bond yields and Bermuda capital releases fund the buyback pace cleanly, or commercial loan defaults and unrecoverable tax losses keep draining capital. The December 3 analyst briefing and fourth-quarter loan disclosures will tell.
🐂 Bull Case
U.S. Sales and Profit Margin Step Up
Aflac U.S. sells supplemental health, life and disability insurance through workplaces. New annualized premium sales — the yearly value of policies sold this quarter — rose 3.5% from a year ago to $403 million, led by network dental, group life and disability policies. Policyholders also kept their coverage longer: premium persistency, the share of policies still active after a year, rose 0.7 percentage points to 79.7%.
Better retention and higher sales lifted U.S. net earned premiums — the policy revenue Aflac recognizes as coverage runs — by 3.3% to $1.54 billion. At the same time, the annual review of insurance reserve assumptions released more reserves in the U.S. than a year ago. That cut benefits and claims by 4.9 percentage points of premiums to 40.7%, while operating expenses fell 1.9 percentage points of revenue to 37.0%, pushing pretax profit excluding one-offs up 31.5% to $493 million.
What to watch: fourth-quarter U.S. net earned premiums, which is the peak enrollment season. By our math, meeting the full-year ceiling of 3% growth leaves at most 2.9% growth for the fourth quarter.
Reinsurance Frees Japan Capital and Lifts Yields
Aflac uses its Bermuda reinsurance subsidiary, Aflac Re Bermuda, to take on policy obligations from its Japanese unit and free up capital. In the third quarter, Aflac Japan transferred about ¥500 billion of cancer insurance reserves, measured under Japanese Financial Services Agency (FSA) rules, to the Bermuda unit. Chief executive Daniel P. Amos said the results show the effect of this reinsurance strategy inside the Corporate and Other segment.
Alongside the reserve transfer, the supplemental insurer has been selling lower-yielding bonds to buy higher-yielding ones. In Japan, the book yield on the investment portfolio — the annual return on bonds and loans held at cost — rose 0.23 percentage points from a year ago to 3.51%, lifting yen investment income excluding one-offs by 3.7%. Corporate segment pretax profit excluding one-offs also improved to $72 million from a $10 million loss last quarter.
What to watch: the December 3 financial analyst briefing and fourth-quarter Japan cash remittances to the parent company. Those disclosures will show how much cash the ¥500 billion reserve transfer frees up for future share buybacks.
Share Buybacks Cushion the Profit Drop
Amos said the insurer remains focused on "more profitable growth and the tactical, opportunistic deployment of capital". In the third quarter, Aflac spent $804 million to buy back 6.8 million of its own shares and paid $305 million in dividends, returning $1.1 billion in total. Over the first nine months of 2026, share repurchases reached $2.79 billion.
Those steady repurchases lowered the diluted share count by 6.3% from a year ago to 498.7 million shares. Because the profit is split among fewer shares, an 8.5% drop in third-quarter profit excluding one-offs turned into a 2.4% dip per share, or a 1.2% dip before currency swings. For the first nine months, profit per share excluding one-offs held flat at $5.92 even though total profit fell 6.0%.
What to watch: fourth-quarter share repurchases and parent-company cash balances in the annual filing. A slowdown below the $800 million quarterly pace would signal that lower cash dividends from Japan are tightening parent liquidity.
🐻 Bear Case
Portfolio Trades and Loan Losses Cut Net Profit
"Aflac delivered solid adjusted earnings for the quarter and for the first nine months," Amos said. That profit measure excludes investment sales and credit write-downs, which cut reported net earnings by 81.5% from a year ago to $303 million, or $0.61 per share. The gap came from "realized losses associated with the strategic repositioning of the portfolio during the third quarter" and ongoing commercial loan stress.
- Realized losses on asset sales and redemptions: $842 million, as Aflac sold older bonds to buy higher-yielding assets
- Credit loss provisions (CECL — reserves for expected loan defaults): $102 million, up from $53 million a year ago
- Tax valuation allowance: $51 million ($0.10 per share) written off against deferred tax assets for capital loss carryforwards
- Transitional real estate loan book: cut 30.3% from a year ago to $2.82 billion as troubled property loans paid down or moved off the books
This matters because profit excluding one-offs counts the higher interest income from the new bonds while leaving out the $842 million loss taken to buy them. Moreover, the $51 million tax write-off shows Aflac could not generate enough capital gains to use all the tax credits from those losses.
What to watch: fourth-quarter credit loss provisions and nonaccrual loan balances in the quarterly filing. Another $100 million credit provision would show that commercial property defaults are still rising despite the smaller loan book.
Smaller Reserve Release Hits Japan Profit
Every third quarter, Aflac reviews the health, claim and lapse assumptions behind its insurance reserves. This process of "unlocking actuarial assumptions" released $453 million of reserves into pretax profit this quarter, down from $580 million in the third quarter of 2025. Stripping out those annual reserve releases from both periods, consolidated pretax profit excluding one-offs was $1,073 million, down 0.6% from $1,080 million a year ago by our math.
The smaller reserve release hit Aflac Japan hardest. Its net benefits and claims jumped 22.5% in yen, lifting the Japan benefit ratio — claims as a share of earned premiums — by 9.9 percentage points to 49.2%. Japan operating expenses also rose 1.4 percentage points of revenue to 21.2%, pulling Japan pretax profit in yen down 15.2% to ¥152.3 billion.
What to watch: Aflac Japan's fourth-quarter benefit ratio, when no annual assumption review takes place. A reading above 63% would show that policy lapses on newer cancer policies are still hurting margins.
Japan Policy Base Keeps Shrinking
Aflac Japan's net earned premiums fell 2.0% in yen to ¥240.3 billion. The company attributed the drop to external and internal reinsurance transfers and older limited-pay policies reaching paid-up status, where customers stop paying premiums but keep coverage. Policy retention also slipped: twelve-month rolling premium persistency fell 0.4 percentage points from a year ago to 92.9%.
New annualized premium sales in Japan fell 4.0% to ¥18.8 billion because the quarter lapped the March 2025 launch of Miraito, its updated cancer insurance policy. Growth in Tsumitasu, a savings-type life insurance product refreshed in the second quarter, and Anshin Palette, a medical policy launched in December 2025, cushioned the drop. Even so, nine-month sales of ¥56.1 billion remain below the pace needed to stop the policy base from shrinking.
What to watch: fourth-quarter Japan new sales in yen. By our math, Aflac needs at least ¥17.9 billion of fourth-quarter sales — a drop of no more than 10.1% from a year ago — to beat last year's ¥74.0 billion total.
Risks this quarter didn't answer
Three standing concerns from prior quarters got no new numbers in the earnings release or financial supplement, and await the quarterly 10-Q filing.
- June 2026 Japan cyber intrusion and June 2025 U.S. network incident: listed only in forward-looking risk factors; the 10-Q legal and contingency notes will show if remediation costs can now be estimated.
- U.S. traditional individual agent sales versus group and buy-to-build lines: the release gave only total U.S. sales (+3.5%); the 10-Q product breakdown will show whether core individual policies stopped shrinking.
- Commercial loan delinquencies and rate modifications: the supplement showed the $102 million credit loss and smaller loan book, but 90-day past-due and nonaccrual tables arrive in Note 3 of the 10-Q.
👓 Other Themes
Weaker Yen Trims Dollar Results
Because Aflac Japan collects premiums in yen and never converts them into dollars, a weaker yen reduces the dollar value of its results on Aflac's U.S. financial statements. The yen averaged 158.49 per dollar in the third quarter, 6.8% weaker than 147.68 a year ago. That currency move cut profit per share excluding one-offs by $0.03 in the quarter and $0.10 over the first nine months.
💲 Other KPIs
Policy liabilities — the money Aflac sets aside to pay future insurance claims — fell 15.0% from $74.74 billion a year ago and 8.7% from year-end 2025. Higher market interest rates raised the discount rate used to value future claims, which lowered the required reserve balance on the balance sheet and added $12.26 billion to shareholders' equity.
Shareholders' equity per share excluding unrealized market and reserve discount swings rose 1.7% from $53.33 a year ago, slowing from 6.2% growth in the second quarter. When cumulative foreign currency gains of $13.48 per share are also stripped out, the underlying book value per share fell 6.4% from a year ago to $40.73 because of realized investment losses and share buybacks above book value.
Annualized profit excluding one-offs as a percentage of average equity (excluding unrealized market swings and currency gains) rose 0.6 percentage points from 23.1% a year ago, and stepped up from 16.6% in the second quarter because the annual reserve assumption review always lifts third-quarter earnings. Reported U.S. GAAP return on equity dropped to 4.1% from 23.5% on bond sale losses.
🔮 Guidance
Unchanged from the first three quarters of 2026. The board of directors declared a fourth-quarter cash dividend of $0.61 per share, up 5.2% from the $0.58 paid in the fourth quarter of 2025. This declaration marks Aflac's 44th straight year of annual dividend increases.
❓ Key Questions
Why did Aflac book a $51 million tax valuation allowance?
Aflac wrote off $51 million of deferred tax assets tied to capital loss carryforwards while taking $842 million in realized sale losses. Investors need to know if Aflac has run out of harvestable foreign currency gains to offset bond repositioning losses.
How much cash did the ¥500 billion Bermuda transfer free?
Aflac Japan ceded ¥500 billion of cancer insurance reserves to Aflac Re Bermuda in the third quarter. Management has not stated how much distributable capital this freed up or whether it will restore Japan's cash remittances to the parent company.
Are transitional real estate loan delinquencies still rising?
Aflac recorded another $102 million in credit loss provisions even as its transitional real estate loan book shrank 30% from a year ago to $2.82 billion. How much of the remaining book is 90 days past due or in foreclosure?
What is the cost of the June 2026 Japan cyber breach?
The June 2026 cyber intrusion at Aflac Japan exposed customer bank-account and policy data, yet the release gave no cost estimate. Has Japan's regulator required remediation steps or sales restrictions that could affect fourth-quarter results?